You have 3 free articles left this month. Get your free Basic subscription now and gain instant access to more.

Turkish drug maker Abdi Ibrahim licensed for Covid-19 vaccine production - report

Turkish drug maker Abdi Ibrahim licensed for Covid-19 vaccine production - report Photo: Pixabay

ANKARA (Turkey), January 7 (SeeNews) - Turkish pharmaceuticals company Abdi Ibrahim Ilac Sanayi Ve Ticaret received the green light from the country's health ministry to manufacture and fill vials of inactive as well as messenger RNA-based vaccines against the novel coronavirus disease (Covid-19), local media reported on Thursday.

"We are currently capable of producing 20 million vaccines," Anadolu Agency quoted the company's chairman Nezih Barut as saying.

According to Barut, the drug maker has the technology and infrastructure needed for vaccine production and vial-filling and is also prepared to provide additional investment in the short term if the production of greater amounts of Covid-19 vaccines is required.

In September, Abdi Ibrahim indirectly acquired a 28.5% stake in Swiss OM Pharma, a biotech firm which develops respiratory and urinary tract medications.

Istanbul-headquartered Abdi Ibrahim, founded in 1912, has the largest product portfolio in the local pharmaceuticals sector, exceeding 200 brands and more than 450 products.  The company operates in 12 countries outside Turkey, exports to more than 60 countries and creates the highest employment with nearly 4,500 qualified employees in the Turkish pharmaceutical industry, according to data published on the company's LinkedIn profile. 

 

 

 
Compare